Roger Strair
- Hematology top 5%
- Acute Myeloid Leukemia Research 8
- Hematopoietic Stem Cell Transplantation 6
-
- Lymphoma Diagnosis and Treatment 6
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 8
- Virus-based gene therapy research 6
- Oncology top 10%
- CAR-T cell therapy research 5
- Cancer Treatment and Pharmacology 5
- Cancer Research top 10%
-
- Retinoids in leukemia and cellular processes 5
- Co-authors
- David A. ShafritzSing Hiem YapDale SchaarDaniel MedinaTing YiLauri GoodellArnold B. RabsonDirk F. Moore
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Roger Strair
65 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 107
- Hematology 257
- Pathology and Forensic Medicine 325
- Genetics 180
- Oncology 422
- Cancer Research 209
Countries citing papers authored by Roger Strair
This map shows the geographic impact of Roger Strair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Strair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Strair more than expected).
Fields of papers citing papers by Roger Strair
This network shows the impact of papers produced by Roger Strair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Strair. The network helps show where Roger Strair may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roger Strair, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2017 | 1 | |
| 4 | 2017 | 10 | |
| 5 | 2012 | 73 | |
| 6 | 2012 | 4 | |
| 7 | 2010 | 62 | |
| 8 | 2009 | 116 | |
| 9 | Increased doses of an anti-CD30 antibody, MDX-060, results in prolonged progression free survival in subjects with CD30 positive lymphoma. | 2008 | 2 |
| 10 | 2008 | 16 | |
| 11 | 2008 | 12 | |
| 12 | 2005 | 12 | |
| 13 | 2005 | 4 | |
| 14 | 2003 | 6 | |
| 15 | 2003 | 4 | |
| 16 | 1996 | 16 | |
| 17 | 1996 | 2 | |
| 18 | 1994 | 58 | |
| 19 | 1993 | 11 | |
| 20 | 1992 | 28 |
About Roger Strair
Roger Strair is a scholar working on Hematology, Oncology and Genetics, having authored 68 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Acute Myeloid Leukemia Research (8 papers), Virus-based gene therapy research (6 papers), Hematopoietic Stem Cell Transplantation (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Retinoids in leukemia and cellular processes (5 papers), CAR-T cell therapy research (5 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Hematology (257 citations), Pathology and Forensic Medicine (325 citations) and Genetics (180 citations). Roger Strair has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include David A. Shafritz, Sing Hiem Yap, Dale Schaar, Daniel Medina, Ting Yi, Lauri Goodell, Arnold B. Rabson, Dirk F. Moore, John F. DiPersio and Wendy Stock. Their work appears in journals such as Journal of Clinical Oncology, Blood, Journal of Virology, Transfusion and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.